Date	Period	Revenue/Estimate	Earnings Call
Aug 26, 2024	2024/Q2	146.947M / 315.000M	--
Apr 24, 2024	2024/Q1	245.116M / 309.000M	--
--	2023/Q4	241.729M / 253.000M	--
Oct 26, 2023	2023/Q3	193.123M / 302.000M	--
Aug 25, 2023	2023/Q2	286.930M / 310.000M	--

DatePeriodRevenue/EstimateEarnings Call

Aug 26, 20242024/Q2146.947M / 315.000M--

Apr 24, 20242024/Q1245.116M / 309.000M--

--2023/Q4241.729M / 253.000M--

Oct 26, 20232023/Q3193.123M / 302.000M--

Aug 25, 20232023/Q2286.930M / 310.000M--

Unlock Free Earnings Estimates

Open Account

Shuanglu Pharmaceutical: Report for the third quarter of 2024

Oct 25 12:00 ET

Beijing Sl Pharmaceutical: Half-year report for the year 2024.

Aug 25 12:00 ET

Beijing Sl Pharmaceutical: Summary of Half-Year Report in 2024.

Aug 25 12:00 ET

Beijing Sl Pharmaceutical: Beijing SL Pharmaceutical Co., Ltd. announces its performance forecast for the first half of 2024.

Jul 10 12:00 ET

Symbol Price % Chg

See the daily top gainer.